- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3306
10-year publication summary
181
|
248
|
223
|
295
|
268
|
270
|
297
|
302
|
291
|
96
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 11238 |
59 |
Deciphera Pharmaceuticals, LLC | 177 |
54 |
F. Hoffmann-La Roche AG | 7958 |
47 |
Bristol-myers Squibb Company | 5080 |
43 |
Bayer Pharma AG | 1096 |
42 |
Merck Patent GmbH | 5909 |
41 |
Incyte Corporation | 918 |
41 |
Boehringer Ingelheim International GmbH | 4629 |
37 |
Immunomedics, Inc. | 290 |
36 |
Merck Sharp & Dohme LLC | 3689 |
33 |
Takeda Pharmaceutical Company Limited | 2961 |
28 |
Pfizer Inc. | 3322 |
26 |
Hoffmann-La Roche Inc. | 3060 |
25 |
Bayer AG | 3045 |
24 |
Merck Sharp & Dohme Corp. | 2247 |
23 |
Gilead Sciences, Inc. | 1879 |
23 |
Amgen Inc. | 3779 |
22 |
Genentech, Inc. | 3742 |
21 |
Mayo Foundation for Medical Education and Research | 2981 |
21 |
Neurocrine Biosciences, Inc. | 381 |
20 |
Other owners | 2640 |